Phare Bio receives ARPA-H funds for AI drug discovery platform

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug discovery platform

Sep 28, 2024 - 04:00

Phare Bio receives ARPA-H funds for AI drug discovery platform

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug discovery platform

Read the original article

Tags:

Previous Article

Tempus AI expands oncology collaboration with Takeda

Physicians highlight need for improved non-opioid treatments for opioid use diso...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

PB-357 by Puma Biotechnology for Breast Cancer: Likelih...

Jun 11, 2023

BMS and Prime ink potential $3.5bn deal to develop T cell therapies

BMS and Prime ink potential $3.5bn deal to develop T ce...

Oct 2, 2024

STAT+: An injectable gel enters the male birth control fray with early positive clinical data

STAT+: An injectable gel enters the male birth control ...

Jan 4, 2024